Osteogenic Growth Peptide (10-14)

<strong>Osteogenic Growth Peptide (10-14)</strong>_x000D_ <strong>Catalog number:</strong> B2019274_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80°C_x000D_ <strong>Keywords:</strong> 105250-85-9 | Historphin | Osteogenic Growth Peptide (10-14) | Tyrosyl-glycyl-phenylalanyl-glycyl-glycine | Tyr-gly-phe-gly-gly | ogp(10-14) | H-Tyr-Gly-Phe-Gly-Gly-OH | 2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-3-phenylpropanoy_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Chen YC, Muhlrad A, Shteyer A, Vidson M, Bab I, Chorev M. Bioactive pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide, OGP(10-14) J Med Chem. 2002 Apr 11;45(8):1624-32._x000D_ 2: Chen ZX, Chang M, Peng YL, Zhao L, Zhan YR, Wang LJ, Wang R. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes Regul Pept. 2007 Jul 5;142(1-2):16-23._x000D_ 3: Battolla B, Bernardini N, Petrini M, Mattii L. The small peptide OGP(10-14) reduces proliferation and induces differentiation of TPO-primed M07-e cells through RhoA/TGFbeta1/SFK pathway Med Sci Monit. 2011 Jan;17(1):SC1-5._x000D_ 4: Fazzi R, Pacini S, Testi R, Azzarà A, Galimberti S, Testi C, Trombi L, Metelli MR, Petrini M. Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis Br J Haematol. 2003 Apr;121(1):76-85._x000D_ 5: Spreafico A, Frediani B, Capperucci C, Leonini A, Gambera D, Ferrata P, Rosini S, Di Stefano A, Galeazzi M, Marcolongo R. Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis J Cell Biochem. 2006 Jul 1;98(4):1007-20._x000D_ 6: Chen Z, Chang M, Peng Y, Zhao L, Zhan Y, Wang L, Wang R. Regulation of endochondral ossification by osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] Protein Pept Lett. 2009;16(9):1074-80._x000D_ 7: Fazzi R, Galimberti S, Testi R, Pacini S, Trasciatti S, Rosini S, Petrini M. Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cells Leuk Res. 2002 Sep;26(9):839-48._x000D_ 8: Fazzi R, Galimberti S, Pacini S, Testi R, Azzarà A, Orciuolo E, Trombi L, Metelli MR, Petrini M. Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide III. Action on human megakaryocytopoiesis: focus on essential thrombocythemia Leuk Res. 2004 Oct;28(10):1097-105._x000D_ 9: Kharchenko EP, Bagrov AIa. [Historphin--a new opioid peptide from histone H4] Dokl Akad Nauk SSSR. 1986;289(4):1009-12._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/3567334">10: Kharchenko EP, Bagrov AIa, Sokolova TV. [Pharmacological effect of exogenous histones on muscles] Biull Eksp Biol Med. 1987 Apr;103(4):418-20.</a>_x000D_ _x000D_ <strong>Products Related to Osteogenic Growth Peptide (10-14) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>